AdvanSix Inc. (NYSE:ASIX - Get Free Report)'s stock price dropped 0.5% during trading on Thursday . The company traded as low as $31.21 and last traded at $31.25. Approximately 6,263 shares traded hands during trading, a decline of 96% from the average daily volume of 140,007 shares. The stock had previously closed at $31.41.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on ASIX shares. Piper Sandler lifted their price target on shares of AdvanSix from $35.00 to $39.00 and gave the stock an "overweight" rating in a report on Friday, November 8th. StockNews.com upgraded AdvanSix from a "hold" rating to a "buy" rating in a research note on Wednesday, December 4th.
Read Our Latest Analysis on AdvanSix
AdvanSix Stock Performance
The company has a current ratio of 1.34, a quick ratio of 0.62 and a debt-to-equity ratio of 0.28. The firm's 50-day simple moving average is $30.58 and its two-hundred day simple moving average is $27.77. The company has a market cap of $833.44 million, a PE ratio of 22.11 and a beta of 1.73.
AdvanSix Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.05%. The ex-dividend date was Tuesday, November 12th. AdvanSix's payout ratio is 45.39%.
Insider Activity
In related news, Director Donald P. Newman purchased 5,030 shares of AdvanSix stock in a transaction that occurred on Monday, November 18th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $149,089.20. Following the completion of the transaction, the director now owns 5,030 shares in the company, valued at $149,089.20. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Erin N. Kane sold 5,000 shares of the company's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $30.28, for a total value of $151,400.00. Following the completion of the sale, the chief executive officer now owns 522,795 shares in the company, valued at approximately $15,830,232.60. This represents a 0.95 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,369 shares of company stock valued at $474,058 in the last ninety days. Insiders own 5.60% of the company's stock.
Institutional Trading of AdvanSix
Several institutional investors have recently bought and sold shares of ASIX. Point72 DIFC Ltd purchased a new position in AdvanSix during the second quarter valued at $34,000. Acadian Asset Management LLC purchased a new position in AdvanSix in the 2nd quarter valued at about $36,000. Copeland Capital Management LLC acquired a new stake in AdvanSix in the 3rd quarter worth about $41,000. Allspring Global Investments Holdings LLC acquired a new stake in AdvanSix in the 2nd quarter worth about $51,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in AdvanSix during the 2nd quarter worth approximately $51,000. 86.39% of the stock is owned by institutional investors and hedge funds.
AdvanSix Company Profile
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.